Jared Friedman

Jared is Managing Director, Software and Group Partner at YC. He was cofounder of Scribd, which was funded by Y Combinator in 2006 and grew to be one of the top 100 sites on the web. Jared previously worked at a pioneering AI company and studied computer science at Harvard.


Ginkgo Bioworks (S14) is going public today

Ginkgo Bioworks is the first biotech company YC funded, and today they are going public. To celebrate their IPO, here’s the story of how Ginkgo Bioworks ended up in YC, and what their journey was like as YC’s first biotech company.

How to spin your scientific research out of a university and into a startup

This is advice for people who have done scientific research at a university and are considering starting a company to commercialize it. At YC, we’ve funded more than…

First YC Bio company to start clinical trials

Shasqi is the first YC Bio company to start first-in-human clinical trials for a drug. We’re very excited to share the news that Shasqi is the first YC…

Responding to COVID-19

In order to confront the COVID-19 crisis, we need to immediately mobilize global scientific and technical talent. We have refreshed our Request for Startups, which are concepts we believe are important in the coming decades, to reflect this newest addition: Responding to COVID-19.

YC and Ginkgo Bioworks announce new partnership for synthetic biology startups

Ginkgo Bioworks was the first bio company YC funded, back in summer 2014, which makes us especially delighted to announce a new partnership between YC and Ginkgo. Ginkgo…

How Biotech Startup Funding Will Change in the Next 10 Years

I’ve noticed that raising money for a biotech or other life science company in 2019 looks a lot like raising money for a tech company 10 years ago. Since then, fundamental forces caused fundraising for tech companies to change dramatically. And I believe that they are going to change biotech fundraising very much the way they changed tech company fundraising.

YC Partners With Atomwise to Fund More Bio Companies

We’re going to work with Atomwise to give interested Artificial Intelligence Molecular Screen (AIMS) teams an expedited path to joining YC.

Simple Share Buttons